文献速递消化道肿瘤放疗放疗物理与技术

借助Anatom-e平台对接受新辅助放疗的直肠癌患者临床靶区勾画变异性的影响

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-06-11

本研究选取两例局部晚期直肠癌病例,让放疗医师在遵循2009年美国放射肿瘤学组(RTOG)共识图谱的前提下,分别在使用和不使用Anatom-e数字平台的情况下手动勾画临床靶区(CTV),评估观察者内和观察者间变异性。结果显示,在复杂病例(病例2)中,使用Anatom-e可降低观察者间DSC的变异性并具统计学显著性,但观察者内变异性及病例1的各指标均无显著差异。作者认为该系统可能有助于提高对共享指南和方案的依从性。

要点

  • 在病例2中,使用Anatom-e时观察者间DSC均值0.72(p=0.03),不使用为0.65。
  • 使用Anatom-e使MDA的标准差从2.97降至1.33,但均值差异无统计学显著性(p=0.21)。
  • 病例1的观察者内和观察者间变异性均无显著差异。

核心结论

  • 使用Anatom-e降低了复杂局部晚期直肠癌新辅助放疗计划中CTV勾画的观察者间变异性。
  • 该系统可能有助于提高对共享指南和方案的依从性。

研究设计与样本

  • 多中心研究,选取两例局部晚期直肠癌临床病例。
  • 参与者被要求遵循2009年美国放射肿瘤学组(RTOG)共识图谱,分别在第1天和第2天(间隔一周)使用和不使用Anatom-e手动勾画临床靶区(CTV)。
  • 采用Dice相似系数(DSC)、Hausdorff距离(HD)和平均一致距离(MDA)评估观察者内和观察者间变异性。

主要发现

  • 病例1:观察者内和观察者间变异性均无显著差异。
  • 病例2:观察者内变异性无显著差异;观察者间DSC在使用Anatom-e时均值0.72(标准差±0.39,范围0.67-0.77),不使用(第1天 vs 参考体积)时均值0.65(标准差±0.64,范围0.58-0.79),差异有统计学显著性(p=0.03)。
  • 病例2:使用Anatom-e时MDA均值3.61(标准差±1.33,范围2.85-4.78),不使用为4.14(标准差±2.97,范围2.18-5.21),差异无统计学显著性(p=0.21);使用Anatom-e使标准差从2.97降至1.33。
  • 病例2:使用Anatom-e时HD均值26.06(标准差±2.05,范围24.08-32.62),不使用为31.39(标准差±1.31,范围26.14-48.72),差异无统计学显著性(p=0.14)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e Information Sytems Ltd., Houston, Texas) in increasing the compliance to follow a specific treatment protocol in a multicentric setting. MATERIALS AND METHODS: Two clinical cases of locally advanced rectal cancer were chosen. Participants were instructed to follow the 2009 Radiation Therapy Oncology Group consensus atlas and asked to manually segment clinical target volumes (CTVs), for both patient 1 and 2, on day 1 with and without the use of Anatom-e. After one week (day 2), the same radiation oncologist contoured again, with and without Anatom-e, the same CT series. Intraobserver (Intra-OV) and interobserver (Inter-OV) variability were evaluated with the Dice similarity coefficient (DSC), the Hausdorff distance (HD) and mean distance to agreement (MDA). RESULTS: For clinical case 1, no significant difference was found for Intra-OV and Inter-OV. For clinical case 2, no significant difference was found for Intra-OV but a statistically significant difference was found for Inter-OV in DSC when using or not the platform. Mean DCS was 0.65 (SD: ±0.64; range: 0.58-0.79) for day 1 vs reference volume without Anatom-e and 0.72 (SD: ±0.39; range: 0.67-0.77) (p = 0.03) with it. Mean MDA was lower with Anatom-e (3.61; SD: ±1.33; range: 2.85-4.78) than without (4.14; SD: ±2.97; range: 2.18-5.21), with no statistical significance (p = 0.21) The use of Anatom-e decreased the SD from 2.97 to 1.33. Mean HD was lower with Anatom-e (26.06; SD: ±2.05; range: 24.08-32.62), with no statistical significance (p = 0.14) compared to that without (31.39; SD: ±1.31; range: 26.14-48.72). CONCLUSIONS: The use of Anatom-e decreased the Inter-OV in the CTV delineation process for locally advanced rectal cancer with complex disease presentation planned for neoadjuvant RT. This system may be potentially helpful in increasing the compliance to follow shared guidelines and protocols.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Franco P, Arcadipane F, Trino E, et al. Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e. Clin Transl Radiat Oncol. 2018. PMID: 29928706. doi:10.1016/j.ctro.2018.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。